Financhill
Back

Takeda Pharmaceutical 10K Form

Sell
22

TAK
Takeda Pharmaceutical

Last Price:
13.89
Seasonality Move:
-5.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TAK News And Ratings

See the #1 stock for the next 7 days that we like better than TAK

TAK Financial Statistics

Sales & Book Value

Annual Sales: $29.83B
Cash Flow: $476.74M
Price / Cash Flow: 0
Annual Sales: $15.24
Price / Book: 0.93

Profitability

EPS (TTM): 0.40140
Net Income (TTM): $1.27B
Gross Margin: $20.61B
Return on Equity: 2.67%
Return on Assets: 1.25%

Takeda Pharmaceutical Earnings Forecast

Key Takeda Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 24 years for TAK is 69.11%.
  • The Selling, General & Administrative Expenses for TAK have been equal to 24.76% of Gross Profit Margin.
  • The Research & Development expenses have been 15.73% of Revenue.
  • The Interest Expense is 36.90% of Operating Income.
  • The Net Earning history of TAK is 7.87% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 15 years.

Takeda Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Current Symbol: TAK
CUSIP: 874060
Website: takeda.com

Debt

Debt-to-Equity Ratio: 0.69
Current Ratio: 1.06
Quick Ratio: 0.46

Price-to-Earnings

Trailing P/E Ratio: 18.98
Forward P/E Ratio: 0

TAK Technical Analysis vs Fundamental Analysis

Sell
22
Takeda Pharmaceutical (TAK) is a Sell

Is Takeda Pharmaceutical a Buy or a Sell?